Abstract: Methods: We reported one cohort of 341 wild-type patients with
COVID-19 admitted at Wuhan, China in 2020 and the other cohort of
336 delta variant patients with
COVID-19 admitted at Yangzhou, China in 2021, with comparisons of their demographic information, medical history, clinical manifestation, and hematological data.